55965-63-4C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1OIYVFNTXFRYQLRP-VVSTWUKXSA-NTroxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
55965-63-4、7085-55-4DTXSID4045929CHEMBL3182320Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 70.8% (63 of 89) of all reports.
Warning
H302 (29.2%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 89 reports by companies from 3 notifications to the ECHA C&L Inventory.
Chemical: 4H-1-Benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
Troxerutin: Does not have an individual approval but may be used under an appropriate group standard
C05CA04
C - Cardiovascular system
QC - Cardiovascular system
No reaction records under the current filter.
Loading…